IDEAYA Biosciences, Inc. (IDYA) [Rocket]

In millions, except per share items	Dec-31-22	Dec-05-22	Dec-31-21	Dec-05-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17
	10-K	8-K	10-K	8-K	10-K	10-K	10-K	10-K
Revenues	50.9	89.5	27.9	58.2	19.5	0.0	0.0	0.0
Revenue growth	82.3%	54.0%	43.0%
Cost of goods sold	0.0	113.4	0.0	78.2	0.0	0.0	0.0	0.0
Gross profit	50.9	-23.9	27.9	-20.1	19.5	0.0	0.0	0.0
Gross margin	100.0%	-26.7%	100.0%	-34.5%	100.0%
Selling, general and administrative [+]	113.4	23.9	78.2	20.1	54.9	10.0	4.7	2.1
General and administrative		23.9		20.1		10.0	4.7	2.1
Research and development						34.3	31.7	12.4
Other operating expenses	-7.7	14.7	-1.0	10.2	-1.7
EBITDA [+]	-52.7		-47.6		-32.2	-43.0	-35.5	-14.0
EBITDA growth	10.8%	24.3%	47.5%		-25.1%	21.1%	152.9%
EBITDA margin	-103.5%	-69.8%	-170.2%	-86.4%	-165.0%
Depreciation and amortization	2.1		1.7		1.4	1.2	0.9	0.4
EBIT [+]	-54.8	-62.5	-49.3	-50.3	-33.6	-44.3	-36.4	-14.4
EBIT growth	11.3%	24.3%	46.5%		-24.0%	21.6%	152.2%
EBIT margin	-107.6%	-69.8%	-176.3%	-86.4%	-172.1%
Interest income								0.2
Interest income								0.2
Other income (expense), net	-3.8	3.8	-0.5	0.5	-0.9	2.3	2.1	2.4
Pre-tax income	-58.7	-58.7	-49.8	-49.8	-34.5	-42.0	-34.3	-11.9
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-58.7	-58.7	-49.8	-49.8	-34.5	-42.0	-34.3	-11.9
Net margin	-115.2%	-65.5%	-178.1%	-85.6%	-176.6%

Basic EPS [+]	($1.42)	($1.42)	($1.41)	($1.41)	($1.40)	($3.36)	($35.92)	($17.06)
Growth	0.3%	0.3%	1.2%		-58.5%	-90.6%	110.6%
Diluted EPS [+]	($1.42)	($1.42)	($1.41)	($1.41)	($1.40)	($3.36)	($35.92)	($17.06)
Growth	0.3%	0.3%	1.2%		-58.5%	-90.6%	110.6%

Shares outstanding (basic) [+]	41.4	41.4	35.3	35.3	24.7	12.5	1.0	0.7
Growth	17.6%	17.6%	42.6%		97.8%	1206.9%	37.5%
Shares outstanding (diluted) [+]	41.4	41.4	35.3	35.3	24.7	12.5	1.0	0.7
Growth	17.6%	17.6%	42.6%		97.8%	1206.9%	37.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.